| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Homocysteine lowering with folic acid and B vitamins in vascular disease.
|
N Engl J Med
|
2006
|
11.72
|
|
2
|
Effect of ramipril on the incidence of diabetes.
|
N Engl J Med
|
2006
|
9.69
|
|
3
|
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.
|
Can J Cardiol
|
2009
|
5.65
|
|
4
|
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.
|
Can J Cardiol
|
2006
|
4.02
|
|
5
|
Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
|
CMAJ
|
2003
|
3.85
|
|
6
|
Results of the Ontario survey on the prevalence and control of hypertension.
|
CMAJ
|
2008
|
2.88
|
|
7
|
Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.
|
CMAJ
|
2011
|
2.34
|
|
8
|
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
|
Can J Cardiol
|
2005
|
2.03
|
|
9
|
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
|
Can J Cardiol
|
2007
|
2.01
|
|
10
|
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
|
Can J Cardiol
|
2012
|
1.86
|
|
11
|
Effect of telmisartan on renal outcomes: a randomized trial.
|
Ann Intern Med
|
2009
|
1.85
|
|
12
|
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.
|
Can J Cardiol
|
2013
|
1.85
|
|
13
|
Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
|
Nephrol Dial Transplant
|
2007
|
1.67
|
|
14
|
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
|
Can J Cardiol
|
2006
|
1.67
|
|
15
|
The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.
|
Can J Cardiol
|
2002
|
1.49
|
|
16
|
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
|
Can J Cardiol
|
2010
|
1.44
|
|
17
|
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.
|
Can J Cardiol
|
2009
|
1.42
|
|
18
|
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
|
Can J Cardiol
|
2011
|
1.38
|
|
19
|
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
|
Can J Cardiol
|
2008
|
1.25
|
|
20
|
Age, gender, and urban-rural differences in the correlates of physical activity.
|
Prev Med
|
2004
|
1.15
|
|
21
|
Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP).
|
Am J Hypertens
|
2008
|
1.15
|
|
22
|
The analysis by Manuel and colleagues creates controversy with headlines, not data.
|
CMAJ
|
2005
|
0.97
|
|
23
|
Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).
|
Can J Cardiol
|
2005
|
0.94
|
|
24
|
What is the feasibility of implementing effective sodium reduction strategies to treat hypertension in primary care settings? A systematic review.
|
J Hypertens
|
2014
|
0.87
|
|
25
|
Application of the 1998 Canadian cholesterol guidelines to a military population: health benefits and cost effectiveness of improved cholesterol management.
|
Can J Cardiol
|
2003
|
0.83
|
|
26
|
Dietary counselling for dyslipidemia in primary care: results of a randomized trial.
|
Can J Diet Pract Res
|
2002
|
0.78
|
|
27
|
Obesity and the prevalence and management of hypertension in Ontario, Canada.
|
Am J Hypertens
|
2010
|
0.77
|
|
28
|
Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study--observational.
|
Curr Med Res Opin
|
2009
|
0.77
|